Michael John Tomsicek
Independent Non-Executive DirectorMr. Michael John Tomsicek, also known as Mike, M.B.A., has been an Independent Director at Acrivon Therapeutics, Inc. since October 2022. Mr. Tomsicek joined the Acrivon Therapeutics, Inc. in October 2022. He had been Chief Financial Officer of CRISPR Therapeutics AG since November 2017 until October 14, 2021 and remained in an advisory role through the end of 2021 to help ensure a smooth transition. Mr. Tomsicek served as the Chief Financial Officer, Vice President and Treasurer of ABIOMED, Inc. since July 15, 2015 until August 24, 2017. Mr. Tomsicek served as the Chief Financial Officer at Cubist Pharmaceuticals Inc. from March 2013 to July 2015. He served as Chief Financial Officer of Lexington. Mr. Tomsicek served as Deputy Chief Financial Officer of Cubist Pharmaceuticals Inc. from July 2, 2012 to March 2013. Mr. Tomsicek served as Senior Vice President of Cubist Pharmaceuticals Inc. from July 2, 2012 to July 2015. Mr. Tomsicek joined Cubist in 2010 and held a series of roles of increasing responsibility leading finance, Investor Relations and strategic sourcing through a period of dynamic growth at the company. He served at General Electric Healthcare, initially as Global Operations Finance Manager for its Monitoring business and Chief Financial Officer of Diagnostic Ultrasound Business and Chief Financial Officer of Global Ultrasound Product Group. Mr. Tomsicek began his career in manufacturing consulting for a Boston area start up. Mr. Tomsicek served in a variety of financial and channel management roles at Motorola. He has been Independent Director of Milestone Pharmaceuticals Inc. since April 4, 2019. He graduated from the University of Wisconsin with a BS in Industrial Engineering and has an MBA from the University of Wisconsin. He had been a Director of Optimer Pharmaceuticals, Inc. since October 24, 2013.
Positions
- Company NameMilestone Pharmaceuticals Inc.Stock CodeMISTPositionIndependent Non-Executive DirectorColleagues
- JGJoseph G. OlivetoCEO, President & Executive Director
- RJRobert James WillsIndependent Chairman of the Board
- AHAmit HasijaCFO & Executive VP of Corporate Development
- DBDavid B. BharuchaChief Medical Officer
- PDPhilippe DouvilleFounder, Strategic Advisor & Member of Scientific Advisory Board
- JNJeffrey NelsonChief Operating Officer
- PTPhilip T. SagerChief Medical Advisor & Member of the Scientific Advisory Board
- Company NameAcrivon Therapeutics, Inc.Stock CodeACRVPositionIndependent DirectorColleagues
- PBPeter Blume-JensenCo-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
- KMKristina MassonCo-Founder, Executive VP of Business Operations, Site Head, Treasurer & Director
- EJEric J. DevroeChief Operating Officer
- ADAdam D. LevyCFO & Principal Financial Officer
- KPKatharine PetersonVice President of Finance & Accounting
- JVJesper V. OlsenAcademic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board
- MJMichael John TomsicekIndependent Director
- CMCharles M. BaumIndependent Director
